Abstract:Tumor has greatly threatened to human life. Now the main means of tumor treatment are surgery and(/or) chemoradiotherapy. However, the chemoradiotherapy is usually not suitable to sustained treatment of tumors due to its poor cell selectivity, side effects and inducing tumor cells resistance. Therefore, it is urgent to develop new drugs with low toxicity and high activity at the tumor sites. In situ self-assembly peptides which can target the tumors and self-assemble into specific nanostructures induced by the specific and highly expressed substances at the tumor tissues are expected to be a new kind of anti-tumor drugs. In this study, we designed a peptide denoted as Fmoc-FFRIKFERQ-OH based on the concept of in situ self-assembly of peptides. This peptide can target lysosomes and self-assemble in situ after being degraded by cathepsin L in lysosomes. The selfassembly properties of Fmoc-FFRIKFERQ-OH and its enzymolysis products degraded by cathepsin L were oberved by AFM and MALDI-TOF-MS. The anti-tumor activity of this peptide was measured by using the MTT and flow cytometry assay. The results demonstrated that cathepsin L could precisely hydrolyze the FmocFFRIKFERQ-OH molecule under acidic conditions in vitro, and its enzymolysis product Fmoc-FFR-OH self-assembled into long nanofibers, which had high antitumor activity against both A375 and SH-SY5Y cells. The relative survival rate was only 36.08% and 25.56% for A375 and SH-SY5Y, respectively. Comparatively, Fmoc-FFRIKFERQ-OH had lower toxic and side effects on normal cells L929. The self-assembled long fibers formed by Fmoc-FFR-OH can disrupt the membrane of lysosome, which can induce cell apoptosis and(/or) death. Thus, the designed Fmoc-FFRIKFERQ-OH is expected to be a new anti-tumor drug due to its high antitumor activity and low toxicity against to normal cells.

Design of an acid-activated antimicrobial peptide for tumor therapy.

Design of pH-responsive antimicrobial peptide melittin analog-camptothecin conjugates for tumor therapy

Design of New Acid-Activated Cell-Penetrating Peptides for Tumor Drug Delivery

New Designed Ph-Responsive Histidine-Rich Peptides with Antitumor Activity.

Functional Properties of a Novel Hybrid Antimicrobial Peptide NS: Potent Antitumor Activity and Efficient Plasmid Delivery.

Aliphatic Acid-Conjugated Antimicrobial Peptides – Potential Agents with Anti-Tumor, Multidrug Resistance-Reversing Activity and Enhanced Stability

Designed Antimicrobial and Antitumor Peptides with High Selectivity.

Peer Review #2 of "design of New Acid-Activated Cell-Penetrating Peptides for Tumor Drug Delivery (V0.1)"

Synthesis and Biological Evaluation of Novel Aliphatic Acid-Conjugated Antimicrobial Peptides As Potential Agents with Anti-Tumor, Multidrug Resistance-Reversing Activity and Enhanced Stability

Acid Active Receptor-Specific Peptide Ligand for in Vivo Tumor-Targeted Delivery

One New Acid-Activated Hybrid Anticancer Peptide by Coupling with a Desirable Ph-Sensitive Anionic Partner Peptide.

Synthesis and Biological Evaluation of Novel Peptides Based on Antimicrobial Peptides As Potential Agents with Antitumor and Multidrug Resistance-Reversing Activities

Design Of A Lysosome Targeting In Situ Self-Assembly Peptide And Its Antitumor Activity

pH-Sensitive micelles with mitochondria-targeted and aggregation-induced emission characterization: synthesis, cytotoxicity and biological applications.

Design and Characterization of a Multifunctional Ph‐triggered Peptide C8 for Selective Anticancer Activity

Novel Peptide-Polymer Conjugate with Ph-Responsive Targeting/Disrupting Effects on Biomembranes.

Design, synthesis and biological evaluation of novel peptides as potential agents with anti-tumor and multidrug resistance-reversing activities

Acid-Activated Melittin for Targeted and Safe Antitumor Therapy.

Development of an Anti-Microbial Peptide-Mediated Liposomal Delivery System: A Novel Approach Towards Ph-Responsive Anti-Microbial Peptides

Design of Acid-Activated Cell Penetrating Peptide for Delivery of Active Molecules into Cancer Cells.

Design of a new pH-activatable cell-penetrating peptide for drug delivery into tumor cells.